Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Nemaura Medical Inc.ex32x2.htm
EX-31.2 - EXHIBIT 31.2 - Nemaura Medical Inc.ex31x2.htm
EX-31.1 - EXHIBIT 31.1 - Nemaura Medical Inc.ex31x1.htm
10-K/A - FORM 10-K/A - Nemaura Medical Inc.nemaura_10k-033117.htm

EXHIBIT 32.1

WRITTEN STATEMENT
PURSUANT TO
18 U.S.C. SECTION 1350

In connection with Annual Report of Nemaura Medical Inc. and its subsidiaries (the " Company ") on Form 10-K/A for the year ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Dewan F H Chowdhury, Chief Executive Officer (Principal Executive Officer) of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the requirements of Section 13a-14(b) or 15d-14(b) of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


  Date: April 10, 2018
 
By: Dewan F.H. Chowdhury 
Name: Dewan F.H. Chowdhury 
Title: Chief Executive Officer
(Principal Executive Officer)